FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294192140> ?p ?o ?g. }

• W4294192140 endingPage "830.e7" @default.
• W4294192140 startingPage "830.e1" @default.
• W4294192140 abstract "Autologous hematopoietic stem cell transplantation (HSCT) is often complicated by hemostatic and thrombotic events associated with endothelial cell injury. Thrombotic complications are affected by a disturbed balance between platelets, circulating von Willebrand factor (VWF), and its specific protease, ADAMTS13. HSCT-associated endothelial dysfunction, impaired hemostasis, and inflammation are interrelated processes, and research on the complex interplay of conditioning regimens from engraftment to bone marrow regeneration remains intensive. This prospective observational study comparing lymphoma and multiple myeloma (MM) patients who underwent autologous HSCT explored how platelet count, VWF level, ADAMTS13 activity, and C-reactive protein (CRP) level as potential markers (1) vary in response to therapy, (2) differ between the 2 groups, and (3) correlate with the remission state at 100 days after HSCT. We correlated the quantitative changes in platelet count and levels of VWF, ADAMTS13, and CRP with one another during HSCT and in the remission state in 45 patients with lymphoma and 59 patients with MM who underwent autologous HSCT between 2010 and 2013 at the University of Debrecen. Samples were collected at the start of conditioning chemotherapy, on the day of stem cell transplantation, and at 5, 11, and 100 days following HSCT. CRP levels peaked when platelet counts dropped to a minimum, and these changes were much more pronounced in the lymphoma group. VWF level was the highest, with lower ADAMTS13 activity, at platelet engraftment in both patient groups equally. Diagnostic evidence indicative of thrombotic complications was not found. In the lymphoma group, VWF level prior to conditioning had statistically significant correlations with platelet count, CRP level, and hemoglobin concentration at the time of bone marrow regeneration (P < .001) and during the remission state (P = .034). In the MM group, platelet count before conditioning was correlated with platelet count (P < .001) and white blood cell count (P = .012) at the time of bone marrow regeneration. The statistically significant correlation of the markers at the time of bone marrow regeneration with the preconditioning VWF levels in lymphoma and with the preconditioning platelet counts in MM might indicate the clinical significance of the bone marrow niches of arterioles and megakaryocytes, respectively, where the stem cells are located and regulated. Because preconditioning VWF levels are associated with remission after HSCT in lymphoma patients, VWF should be screened before conditioning, along with the markers used in HSCT protocols, to optimize personalized treatment and reduce therapeutic risks." @default.
• W4294192140 created "2022-09-02" @default.
• W4294192140 creator A5009369647 @default.
• W4294192140 creator A5012342629 @default.
• W4294192140 creator A5017745159 @default.
• W4294192140 creator A5031942816 @default.
• W4294192140 creator A5047147949 @default.
• W4294192140 creator A5060655206 @default.
• W4294192140 creator A5061533135 @default.
• W4294192140 creator A5077100342 @default.
• W4294192140 creator A5078310903 @default.
• W4294192140 date "2022-12-01" @default.
• W4294192140 modified "2023-10-16" @default.
• W4294192140 title "Von Willebrand Factor and Platelet Levels before Conditioning Chemotherapy Indicate Bone Marrow Regeneration following Autologous Hematopoietic Stem Cell Transplantation" @default.
• W4294192140 cites W1968478912 @default.
• W4294192140 cites W2002093270 @default.
• W4294192140 cites W2023981517 @default.
• W4294192140 cites W2032827256 @default.
• W4294192140 cites W2041820995 @default.
• W4294192140 cites W2080388518 @default.
• W4294192140 cites W2105430482 @default.
• W4294192140 cites W2108861120 @default.
• W4294192140 cites W2117648429 @default.
• W4294192140 cites W2117803220 @default.
• W4294192140 cites W2136373453 @default.
• W4294192140 cites W2139017394 @default.
• W4294192140 cites W2145095230 @default.
• W4294192140 cites W2418658443 @default.
• W4294192140 cites W2567940562 @default.
• W4294192140 cites W2736836364 @default.
• W4294192140 cites W2805098025 @default.
• W4294192140 cites W2811480666 @default.
• W4294192140 cites W2834234875 @default.
• W4294192140 cites W2883683026 @default.
• W4294192140 cites W2914523197 @default.
• W4294192140 cites W2917965199 @default.
• W4294192140 cites W2937249860 @default.
• W4294192140 cites W2970421739 @default.
• W4294192140 cites W3008776356 @default.
• W4294192140 cites W3017245290 @default.
• W4294192140 cites W3021484626 @default.
• W4294192140 cites W3095576251 @default.
• W4294192140 cites W3112088296 @default.
• W4294192140 cites W3197344562 @default.
• W4294192140 cites W3198096146 @default.
• W4294192140 cites W3203975172 @default.
• W4294192140 cites W3212609199 @default.
• W4294192140 cites W4210425996 @default.
• W4294192140 cites W4232045253 @default.
• W4294192140 cites W4246496739 @default.
• W4294192140 doi "https://doi.org/10.1016/j.jtct.2022.08.028" @default.
• W4294192140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36058547" @default.
• W4294192140 hasPublicationYear "2022" @default.
• W4294192140 type Work @default.
• W4294192140 citedByCount "0" @default.
• W4294192140 crossrefType "journal-article" @default.
• W4294192140 hasAuthorship W4294192140A5009369647 @default.
• W4294192140 hasAuthorship W4294192140A5012342629 @default.
• W4294192140 hasAuthorship W4294192140A5017745159 @default.
• W4294192140 hasAuthorship W4294192140A5031942816 @default.
• W4294192140 hasAuthorship W4294192140A5047147949 @default.
• W4294192140 hasAuthorship W4294192140A5060655206 @default.
• W4294192140 hasAuthorship W4294192140A5061533135 @default.
• W4294192140 hasAuthorship W4294192140A5077100342 @default.
• W4294192140 hasAuthorship W4294192140A5078310903 @default.
• W4294192140 hasBestOaLocation W42941921401 @default.
• W4294192140 hasConcept C126322002 @default.
• W4294192140 hasConcept C143998085 @default.
• W4294192140 hasConcept C203014093 @default.
• W4294192140 hasConcept C2776364478 @default.
• W4294192140 hasConcept C2777408962 @default.
• W4294192140 hasConcept C2779050716 @default.
• W4294192140 hasConcept C2779394231 @default.
• W4294192140 hasConcept C2780007613 @default.
• W4294192140 hasConcept C2780921031 @default.
• W4294192140 hasConcept C28328180 @default.
• W4294192140 hasConcept C2911091166 @default.
• W4294192140 hasConcept C54355233 @default.
• W4294192140 hasConcept C71924100 @default.
• W4294192140 hasConcept C86803240 @default.
• W4294192140 hasConcept C89560881 @default.
• W4294192140 hasConcept C90924648 @default.
• W4294192140 hasConceptScore W4294192140C126322002 @default.
• W4294192140 hasConceptScore W4294192140C143998085 @default.
• W4294192140 hasConceptScore W4294192140C203014093 @default.
• W4294192140 hasConceptScore W4294192140C2776364478 @default.
• W4294192140 hasConceptScore W4294192140C2777408962 @default.
• W4294192140 hasConceptScore W4294192140C2779050716 @default.
• W4294192140 hasConceptScore W4294192140C2779394231 @default.
• W4294192140 hasConceptScore W4294192140C2780007613 @default.
• W4294192140 hasConceptScore W4294192140C2780921031 @default.
• W4294192140 hasConceptScore W4294192140C28328180 @default.
• W4294192140 hasConceptScore W4294192140C2911091166 @default.
• W4294192140 hasConceptScore W4294192140C54355233 @default.
• W4294192140 hasConceptScore W4294192140C71924100 @default.
• W4294192140 hasConceptScore W4294192140C86803240 @default.
• W4294192140 hasConceptScore W4294192140C89560881 @default.
• W4294192140 hasConceptScore W4294192140C90924648 @default.

• next